Related references
Note: Only part of the references are listed.Risk factors of vertebral re-fracture after PVP or PKP for osteoporotic vertebral compression fractures, especially in Eastern Asia: a systematic review and meta-analysis
Chuanqiang Dai et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2022)
UK clinical guideline for the prevention and treatment of osteoporosis
Celia L. Gregson et al.
ARCHIVES OF OSTEOPOROSIS (2022)
Risk factors for secondary fractures to percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a systematic review
Wei Mao et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2021)
Risk Factors for New Vertebral Fracture After Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures
Zi-Long Zhang et al.
CLINICAL INTERVENTIONS IN AGING (2021)
Cushing's syndrome: Treatment and new therapeutic approaches
Amandine Ferriere et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Effects of Different Types of Exercise on Bone Mineral Density in Postmenopausal Women: A Systematic Review and Meta-analysis
Wolfgang Kemmler et al.
CALCIFIED TISSUE INTERNATIONAL (2020)
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Rosario Pivonello et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
G. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Vitamin D and Calcium for the Prevention of Fracture A Systematic Review and Meta-analysis
Pang Yao et al.
JAMA NETWORK OPEN (2019)
Risk factor analysis for re-collapse of cemented vertebrae after percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP)
Yong-xian Li et al.
INTERNATIONAL ORTHOPAEDICS (2018)
Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial
Cristina E. Firanescu et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial
Cristina E. Firanescu et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Percutaneous vertebroplasty for osteoporotic vertebral compression fracture
Rachelle Buchbinder et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Bente L. Langdahl et al.
LANCET (2017)
Percutaneous Vertebroplasty and Kyphoplasty: Current Status, New Developments and Old Controversies
Dimitrios K. Filippiadis et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years
M. H. Thorin et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial
William Clark et al.
LANCET (2016)
Complications of Cushing's syndrome: state of the art
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Bone density and microarchitecture in endogenous hypercortisolism
Camila V. dos Santos et al.
CLINICAL ENDOCRINOLOGY (2015)
The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study
Tomas Thor Agustsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Cushing's syndrome: from physiological principles to diagnosis and clinical care
Hershel Raff et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures An Updated Systematic Review
Carolyn J. Crandall et al.
ANNALS OF INTERNAL MEDICINE (2014)
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants
L. Trementino et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Comparison of the Therapeutic Effect of Teriparatide With That of Combined Vertebroplasty With Antiresorptive Agents for the Treatment of New-onset Adjacent Vertebral Compression Fracture After Percutaneous Vertebroplasty
Chen-Hsing Su et al.
JOURNAL OF SPINAL DISORDERS & TECHNIQUES (2013)
Spontaneous recovery of bone mass after cure of endogenous hypercortisolism
Maria Elena Randazzo et al.
PITUITARY (2012)
Percutaneous vertebroplasty complications
Nizar A. Al-Nakshabandi
ANNALS OF SAUDI MEDICINE (2011)
Mortality and morbidity in Cushing's syndrome in New Zealand
Mark J. Bolland et al.
CLINICAL ENDOCRINOLOGY (2011)
Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures
Majid Reza Farrokhi et al.
JOURNAL OF NEUROSURGERY-SPINE (2011)
Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial
Caroline A. H. Klazen et al.
LANCET (2010)
Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe
B. Abrahamsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe
B. Abrahamsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
Steven Boonen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
S. Aubrey Stoch et al.
JOURNAL OF RHEUMATOLOGY (2009)
A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures
Rachelle Buchbinder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: Prospective study
Akiko Kawamata et al.
WORLD JOURNAL OF SURGERY (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis
Benjamin M. P. Tang et al.
LANCET (2007)
Bone demineralization and vertebral fractures in endogenous cortisol excess:: Role of disease etiology and gonadal status
L Tauchmanová et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome
N Ohmori et al.
ENDOCRINE JOURNAL (2003)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Alendronate for the treatment of osteoporosis in men
E Orwoll et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
JY Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
